# PostEra

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/postera

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.postera.ai
- Total disclosed funding: $26M
- Latest round: Series A (Dec 31, 2021)
- Investors on record: 9

## About

Based in Massachusetts, US, and founded in 2019 by its CEO, Aaron Morris, CTO Matt Robinson, and CSO Alpha Lee, PostEra Inc. is a biotechnology company that uses machine learning for preclinical drug discovery. In January 2022, PostEra Inc. raised USD 24 million in series A financing led by Clermont Group, with Breyer Capital, I2BF, and LifeForce Capital. 

PostEra Inc. offers medicinal chemistry powered by machine learning and reduces their clients' cycle times. The company has developed COVID oral antiviral candidates via the COVID Moonshot, the advancement of several drug discovery efforts with biopharma partners, and the launch of Manifold as an industry synthesis platform. 

PostEra Inc. will use the series A funding to advance a series of partnered drug discovery programs, initiate its own internal drug discovery program, and further develop its medicinal chemistry platform.

## Funding rounds

- Series A, Dec 31, 2021, $26M — I2BF, ACE & Company, Breyer Capital, HOF Capital, LifeForce Capital, Pioneer Fund, Metaplanet Holdings, Clermont Group
- Seed, Mar 16, 2020, $0.1M — Y Combinator, ACE & Company, Pioneer Fund

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- ACE & Company (https://capitalatlas.ai/funds/ace-company) — Seed, Series A
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed, Series A
- I2BF (https://capitalatlas.ai/funds/i2bf) — Series A
- Breyer Capital (https://capitalatlas.ai/funds/breyer-capital) — Series A
- HOF Capital (https://capitalatlas.ai/funds/hof-capital) — Series A
- LifeForce Capital (https://capitalatlas.ai/funds/lifeforce-capital) — Series A
- Metaplanet Holdings (https://capitalatlas.ai/funds/metaplanet-holdings) — Series A
- Clermont Group — Series A